PathogenDx, Inc., an Arizona-based technology company, announced a distribution agreement with Axiology Labs, a South African-based laboratory equipment supply company, for its breakthrough Detectx-Cv ...
(MENAFN- Newsfile Corp) PathogenDx Announces the CE Marking of Its Next-Generation COVID-19 Testing Technology for the Simultaneous Detection of SARS-CoV-2 (COVID-19) and Its Variants The Technology ...
PathogenDx's disruptive nucleic acid-based test uses a multiplex microarray to rapidly identify, detect, and quantify multiple pathogens and viral strains SANTA CLARA, Calif., March 22, 2021 ...
PathogenDx's breakthrough technology shifts the pathogen detection paradigm from microbial to molecular testing through its microarray assays, namely DetectX, EnviroX, and QuantX SANTA CLARA, ...
PathogenDx's disruptive nucleic acid-based test uses a multiplex microarray to rapidly identify, detect, and quantify multiple pathogens and viral strains "PathogenDx's testing technology harnesses ...